ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) is expected to issue its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect ProQR Therapeutics to post earnings of ($0.14) per share and revenue of $4.5610 million for the quarter. ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) last issued its earnings results on Tuesday, May 12th. On average, analysts expect ProQR Therapeutics to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year. Get ProQR Therapeutics alerts:ProQR Therapeutics Stock PerformanceShares of PRQR opened at $1.73 on Thursday.